N, B., CA, K., AL, M., RB, P., G, C., & GN, M. (2023). Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease. Journal of virology, 97(9), e0066923. https://doi.org/10.1128/jvi.00669-23
Chicago Style (17th ed.) CitationN, Bourne, Keith CA, Miller AL, Pyles RB, Cohen G, and Milligan GN. "Boosting of Vaginal HSV-2-specific B and T Cell Responses by Intravaginal Therapeutic Immunization Results in Diminished Recurrent HSV-2 Disease." Journal of Virology 97, no. 9 (2023): e0066923. https://doi.org/10.1128/jvi.00669-23.
MLA (9th ed.) CitationN, Bourne, et al. "Boosting of Vaginal HSV-2-specific B and T Cell Responses by Intravaginal Therapeutic Immunization Results in Diminished Recurrent HSV-2 Disease." Journal of Virology, vol. 97, no. 9, 2023, p. e0066923, https://doi.org/10.1128/jvi.00669-23.